Posted on by Mike Yeomans
Pitt innovators were issued 5 U.S. patents in October 2024. Approximately 1 our of 6 newborns will have some type of hip instability, with 2-3 of every 1,000 requiring surgery. …
Posted on by Mike Yeomans
Pitt innovators were issued 5 U.S. patents in September 2024. Severe asthma consumes 40-50% of asthma-related healthcare costs, amounting to $28 billion each year in the US. Corticosteroids, a mainstay …
Posted on by Mike Yeomans
Pitt innovators were issued 6 U.S. patents in August 2024. Women cancer survivors often struggle with infertility and reproductive dysfunction. Pitt innovators are developing a novel method to support follicle …
Posted on by Mike Yeomans
The Office of Innovation and Entrepreneurship staff are dedicated to helping Pitt faculty and student innovators and regional small businesses make an impact for their ideas and research in the wilder …
Posted on by Mike Yeomans
Andrele St. Val, assistant professor in the University of Pittsburgh School of Law, is developing a platform for improving legal education to build resilience, wellbeing, and inclusivity.
Posted on by Mike Yeomans
Pitt and UPMC Enterprises, through its Translational Sciences division, are collaborating again to provide funding support for therapeutics projects that need further de-risking experiments to enhance their clinical and commercial …
Posted on by Mike Yeomans
Pitt innovators were issued 11 U.S. patents in July 2024. About 35 million Americans have Temporomadibular Joint Disorder (TMJ). In severe cases of this painful condition the joint degenerates to …
Posted on by Mike Yeomans
For Shanae Butler, the Michael G. Wells Student Healthcare Competition taught her that translating scientific discovery into an innovation with commercial potential required honing a new skill: storytelling. “People like …
Posted on by Mike Yeomans
Paul Ohodnicki was no stranger to innovation commercialization when he arrived at the University of Pittsburgh in 2020.
Posted on by Mike Yeomans
Pitt innovators were issued 11 U.S. patents in June 2024. Tuberculosis kills more than 1.5 million people each year. Current treatment is a strict six-month antibiotic regimen with a minimum …
Posted on by Mike Yeomans
Each year the biotech industry gathers to discuss trends, share insights, and explore partnership opportunities at the BIO International Convention, the world’s largest meeting of its kind. The University …
Posted on by Mike Yeomans
Antonio D’Amore arrived at the University of Pittsburgh in 2008 to pursue his doctoral studies in the Department of Bioengineering with an appointment to the prestigious McGowan Institute for Regenerative …